- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Huge Earnings Growth
Global Pharmaceuticals & Biotech Huge Earnings Growth
UPDATED Jul 03, 2022
Companies which grew earnings more than 50% in the last year.
183 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| CDMOAvid Bioservices | US$15.33 | -1.8% | -41.4% | US$947.9m | US$26.67 | PE7.4x | E-57.2% | n/a | ||
| AMPHAmphastar Pharmaceuticals | US$35.35 | 3.1% | 71.5% | US$1.7b | US$41.00 | PE21.2x | S6.8% | n/a | ||
| 4195Genomics BioSci & Tech.Ltd | NT$17.70 | -3.8% | 7.6% | NT$1.1b | n/a | PE58.4x | n/a | 0% | ||
| 542724Earum Pharmaceuticals | ₹3.21 | -20.9% | -42.7% | ₹198.0m | n/a | PE8.9x | n/a | n/a | ||
| MRNAModerna | US$149.95 | 3.2% | -36.0% | US$59.6b | US$213.67 | PE4.1x | E-39.9% | n/a | ||
| 950Lee's Pharmaceutical Holdings | HK$2.09 | 5.6% | -55.7% | HK$1.2b | HK$2.35 | PE0.6x | S9.3% | 2.9% | ||
| BNTXBioNTech | US$157.50 | 9.6% | -29.7% | US$38.3b | US$241.07 | PE2.9x | E-43.1% | n/a | ||
| IGNInno-Gene | zł8.10 | 24.6% | -22.1% | zł46.2m | n/a | PE4x | n/a | n/a | ||
| 300158Shanxi Zhendong PharmaceuticalLtd | CNÂ¥6.77 | -0.9% | -12.1% | CNÂ¥6.8b | n/a | PE2.8x | n/a | 41.4% | ||
| 6118Austar Lifesciences | HK$2.47 | -10.8% | -85.4% | HK$1.3b | n/a | PE3.9x | n/a | 0% | ||
| 524752Decipher Labs | ₹41.10 | -7.8% | 21.1% | ₹415.1m | n/a | PE3.6x | n/a | n/a | ||
| 539997Kwality Pharmaceuticals | ₹301.75 | -8.4% | 62.8% | ₹3.1b | n/a | PE2.6x | n/a | 0% | ||
| 538837Jeevan Scientific Technology | ₹62.15 | 5.0% | -28.9% | ₹951.0m | n/a | PE6.3x | n/a | 0.8% | ||
| KDCEKid Castle Educational | US$0.032 | 0% | n/a | US$714.4k | n/a | PE0.3x | n/a | n/a | ||
| 540694ANG Lifesciences India | ₹178.45 | -13.4% | 227.7% | ₹1.8b | n/a | PE4.6x | n/a | 0.6% | ||
| IDTIDT Australia | AU$0.12 | 9.1% | -63.1% | AU$28.9m | n/a | PE13.2x | n/a | 0% | ||
| 300584Nanjing Hicin Pharmaceutical | CNÂ¥32.65 | 2.5% | 62.7% | CNÂ¥3.8b | n/a | PE13.7x | n/a | 0.8% | ||
| A144510GC Cell | â‚©53,700.00 | -6.3% | -52.6% | â‚©803.4b | n/a | PE15.8x | n/a | 0% | ||
| 1177Sino Biopharmaceutical | HK$5.27 | 10.0% | -28.1% | HK$92.8b | HK$7.77 | PE5.8x | E-38.4% | 1.4% | ||
| GENOGenovis AB (publ.) | kr46.10 | 2.6% | 4.8% | kr3.0b | kr80.00 | PE82.9x | E55.6% | n/a | ||
| ALK BALK-Abelló | kr.127.20 | 3.0% | -17.1% | kr.28.0b | kr.169.88 | PE109.8x | E39.7% | 0% | ||
| VAISHALIVaishali Pharma | ₹82.25 | 0.9% | 86.7% | ₹867.4m | n/a | PE21.6x | n/a | n/a | ||
| IRWDIronwood Pharmaceuticals | US$11.53 | -0.6% | -8.3% | US$1.8b | US$12.50 | PE3.4x | E-2.5% | n/a | ||
| 2309CMIC HOLDINGS | JPÂ¥1,451.00 | 2.3% | -11.0% | JPÂ¥25.3b | JPÂ¥2,100.00 | PE6x | E-19.4% | 2.3% |